BioLife Solutions, Inc.
BLFS
$21.90
$0.914.34%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -111.20% | 7.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -111.20% | 7.92% | |||
| Cost of Revenue | -181.92% | 6.26% | |||
| Gross Profit | -49.24% | 9.41% | |||
| SG&A Expenses | -61.08% | 3.46% | |||
| Depreciation & Amortization | -99.67% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -114.97% | 3.24% | |||
| Operating Income | 188.90% | 44.22% | |||
| Income Before Tax | 189.14% | 75.78% | |||
| Income Tax Expenses | -367.86% | -- | |||
| Earnings from Continuing Operations | 198.30% | 76.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 831.59% | 91.78% | |||
| EBIT | 188.90% | 44.22% | |||
| EBITDA | 263.96% | 275.06% | |||
| EPS Basic | 823.85% | 91.81% | |||
| Normalized Basic EPS | 188.46% | 43.88% | |||
| EPS Diluted | 795.66% | 91.81% | |||
| Normalized Diluted EPS | 185.90% | 43.88% | |||
| Average Basic Shares Outstanding | 1.03% | 0.37% | |||
| Average Diluted Shares Outstanding | 4.02% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
